December 11th, 2017
jobs
homes

Menu
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Avantor, Inc. Common Stock (NY:AVTR)

14.28 -0.01 (-0.07%)
Streaming Delayed Price Updated: 11:37 AM EDT, Oct 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Avantor, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Avantor (NYSE:AVTR) Exceeds Q2 Expectations But Stock Drops
Life sciences company Avantor (NYSE:AVTR) announced better-than-expected revenue in Q2 CY2025, but sales fell by 1.1% year on year to $1.68 billion. Its non-GAAP profit of $0.24 per share was in line... 
Via StockStory
Earnings Scheduled For August 1, 2025
 
Via Benzinga
Earnings Preview For Avantor
 
Via Benzinga
An Overview of Avantor's Earnings
 
Via Benzinga
What To Expect From Avantor’s (AVTR) Q2 Earnings
Life sciences company Avantor (NYSE:AVTR) will be announcing earnings results this Friday before market hours. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence World Trade
Why Avantor (AVTR) Shares Are Trading Lower Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 8% in the afternoon session after the company announced that it has appointed Emmanuel Ligner as its new President and Chief Executive Officer,... 
Via StockStory
3 Small-Cap Stocks Facing Headwinds
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside... 
Via StockStory
2 Profitable Stocks to Target This Week and 1 to Brush Off
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow. 
Via StockStory
3 Healthcare Stocks with Mounting Challenges
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of... 
Via StockStory
Topics Stocks
3 Cash-Producing Stocks with Mounting Challenges
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. 
Via StockStory
Guardant Health, Evolent Health, Charles River Laboratories, Avantor, and Lumen Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that... 
Via StockStory
Topics Bonds Stocks
Waters Corporation, Avantor, Azenta, Bio-Techne, and Elanco Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
AVTR Q1 Earnings Call: CEO Transition and Margin Focus Amid Weak Market Conditions
Life sciences company Avantor (NYSE:AVTR) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was in... 
Via StockStory
Topics Economy World Trade
Q1 Earnings Highs And Lows: Avantor (NYSE:AVTR) Vs The Rest Of The Research Tools & Consumables Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Avantor (NYSE:AVTR) and the best and worst... 
Via StockStory
Topics Economy
3 Small-Cap Stocks with Mounting Challenges
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
Goldman Sachs Downgrades Avantor As Shares Spiral 60% Since 2021: 'We Wrongly Assumed...'
Avantor missed Q1 sales estimates and faced multiple analyst downgrades as concerns mount over growth, competition, and product performance. 
Via Benzinga
Demystifying Avantor: Insights From 16 Analyst Reviews
 
Via Benzinga
Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday
 
Via Benzinga
Avantor Analysts Cut Their Forecasts After Q1 Results
 
Via Benzinga
3 Hated Stocks in the Doghouse
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
This Eli Lilly Analyst Turns Bearish; Here Are Top 4 Downgrades For Monday
 
Via Benzinga
Why Avantor (AVTR) Shares Are Falling Today
Shares of life sciences company Avantor (NYSE:AVTR) fell 21.2% in the afternoon session after the company reported a weak first-quarter 2025 performance, as its organic revenue and total sales both... 
Via StockStory
Topics Artificial Intelligence
Avantor Sees Steady Earnings, Plans Leadership Change And Strategy Shift
Avantor matched EPS expectations but missed revenue targets and cut its outlook as its CEO steps down and cost-saving plans ramp up. 
Via Benzinga
Avantor (NYSE:AVTR) Misses Q1 Revenue Estimates
Life sciences company Avantor (NYSE:AVTR) fell short of the market’s revenue expectations in Q1 CY2025, with sales falling 5.9% year on year to $1.58 billion. Its non-GAAP profit of $0.23 per share was... 
Via StockStory
Topics Economy
Earnings Scheduled For April 25, 2025
 
Via Benzinga
Earnings To Watch: Avantor (AVTR) Reports Q1 Results Tomorrow
Life sciences company Avantor (NYSE:AVTR) will be reporting earnings tomorrow before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
Reflecting On Research Tools & Consumables Stocks’ Q4 Earnings: Agilent (NYSE:A)
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Agilent (NYSE:A) and its peers. 
Via StockStory
Topics Economy
Q4 Rundown: Avantor (NYSE:AVTR) Vs Other Research Tools & Consumables Stocks
Let’s dig into the relative performance of Avantor (NYSE:AVTR) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. 
Via StockStory
Topics Economy
A Look Back at Research Tools & Consumables Stocks’ Q4 Earnings: Mettler-Toledo (NYSE:MTD) Vs The Rest Of The Pack
Let’s dig into the relative performance of Mettler-Toledo (NYSE:MTD) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season. 
Via StockStory
Topics Economy
3 Reasons AVTR is Risky and 1 Stock to Buy Instead
Shareholders of Avantor would probably like to forget the past six months even happened. The stock dropped 38.1% and now trades at $15.67. This was partly due to its softer quarterly results and might... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.